Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?


Like Comment
Related Content

Volume 113, Issue 1, Pages 87–88


Sushila Arya, M.D., Karl R. Hansen, M.D., Ph.D., Robert A. Wild, M.D., M.P.H., Ph.D.


Reflections on "Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial" by Li et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.